Intendis enters market as new dermatology specialist

Berlin, Germany, February 3, 2005 - Intendis GmbH today officially announced, that it has started operations as a new, fully integrated pharmaceutical company, dedicated to the development and marketing of systemic and topical treatments for skin disorders. Intendis is a 100% owned subsidiary of Schering AG, Germany (FSE: SCH, NYSE: SHR).

At a press conference in Berlin today, Intendis management introduced the new company and its growth prospects. It is pursuing a strategy to invest in the marketing of the group�'s well-established dermatology brands in the areas of eczema, psoriasis, acne, rosacea, and fungal infections to broaden their global reach. With its 300-strong sales and marketing organization, the company is already well positioned across major markets. In addition, Intendis is developing new medical entities to further expand the business in areas with the greatest unmet medical need and promising growth. At the same time the company will look for a strategic partner to create critical mass in major markets.

"We are looking forward to growing Intendis into a major specialist dermatology company and to become a partner of choice in our field," said Professor Dr. Wolfgang Kehr, CEO of Intendis GmbH. "We expect that our strong brands and dedication to new product development will ensure sales growth above current market growth. We clearly aim to maximise the growth potential of our business."

Intendis showed pro forma net sales of €200m for 2004 and has the rights to leading dermatology brands transferred from Schering AG, including AdvantanŽ, FinaceaŽ and PsorcutanŽ. It is headquartered in Berlin and has over 600 employees worldwide in manufacturing, development, marketing and sales across ten key dermatology markets.

This press release has been published by Corporate Communication of Intendis GmbH, Berlin, Germany.

Tony Williams, Head of Strategic Marketing and Sales

Tel: +49 30 468 192652



Brunswick Group (London)Brunswick Group (Frankfurt)
Wendel Verbeek/Chi LoHartmut Schumacher
Tel: +44 207 404 5959Tel: +49 69 24 00 5519